Food, drug, insect sting allergy, and anaphylaxis
Early consumption of peanuts in infancy is associated with a low prevalence of peanut allergy

https://doi.org/10.1016/j.jaci.2008.08.039Get rights and content

Background

Despite guidelines recommending avoidance of peanuts during infancy in the United Kingdom (UK), Australia, and, until recently, North America, peanut allergy (PA) continues to increase in these countries.

Objective

We sought to determine the prevalence of PA among Israeli and UK Jewish children and evaluate the relationship of PA to infant and maternal peanut consumption.

Methods

A clinically validated questionnaire determined the prevalence of PA among Jewish schoolchildren (5171 in the UK and 5615 in Israel). A second validated questionnaire assessed peanut consumption and weaning in Jewish infants (77 in the UK and 99 in Israel).

Results

The prevalence of PA in the UK was 1.85%, and the prevalence in Israel was 0.17% (P < .001). Despite accounting for atopy, the adjusted risk ratio for PA between countries was 9.8 (95% CI, 3.1-30.5) in primary school children. Peanut is introduced earlier and is eaten more frequently and in larger quantities in Israel than in the UK. The median monthly consumption of peanut in Israeli infants aged 8 to 14 months is 7.1 g of peanut protein, and it is 0 g in the UK (P < .001). The median number of times peanut is eaten per month was 8 in Israel and 0 in the UK (P < .0001).

Conclusions

We demonstrate that Jewish children in the UK have a prevalence of PA that is 10-fold higher than that of Jewish children in Israel. This difference is not accounted for by differences in atopy, social class, genetic background, or peanut allergenicity. Israeli infants consume peanut in high quantities in the first year of life, whereas UK infants avoid peanuts. These findings raise the question of whether early introduction of peanut during infancy, rather than avoidance, will prevent the development of PA.

Section snippets

Questionnaires

Two validated questionnaires were used. Questionnaires recorded categorical answers only.

FAQ

The FAQs were distributed to 10,786 children in 24 schools (13 in the UK and 11 in Israel). Eight thousand eight hundred twenty-six were returned, resulting in an overall response rate of 81.8% (80.2% [4148/5171] in the UK and 83.2% [4672/5615] in Israel). Two hundred twenty-six FAQs were excluded from analysis (220 were outside the age range [ie, <4 or ≥19 years of age], 2 were duplicates, and 4 had an incorrect school code). Of the 8826 returned FAQs, 7880 were returned after initial sampling

Discussion

Using a questionnaire-based study of 8600 schoolchildren, we have shown that the prevalence of PA is 10-fold higher in Jewish children in the UK compared with that seen in Jewish children in Israel (1.85% and 0.17%, respectively). Furthermore, the prevalence of PA appears to be increasing in the UK, whereas in Israel it remains stable among all age groups. These differences cannot be explained by differences in age, sex, ancestry, atopy, or socioeconomic class. After adjustment for atopy, other

References (47)

  • H. Kerosuo et al.

    Nickel allergy in adolescents in relation to orthodontic treatment and piercing of ears

    Am J Orthod Dentofacial Orthop

    (1996)
  • F.J. Twarog et al.

    Hypersensitivity to pancreatic extracts in parents of patients with cystic fibrosis

    J Allergy Clin Immunol

    (1977)
  • B. Lee et al.

    Food allergy—lessons From Asia

    World Allergy Org J

    (2008)
  • M.I. Asher et al.

    Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys

    Lancet

    (2006)
  • G. Roberts et al.

    Diagnosing peanut allergy with skin prick and specific IgE testing

    J Allergy Clin Immunol

    (2005)
  • H.A. Sampson

    Update on food allergy

    J Allergy Clin Immunol

    (2004)
  • S.J. Maleki et al.

    The effects of roasting on the allergenic properties of peanut proteins

    J Allergy Clin Immunol

    (2000)
  • K. Beyer et al.

    Identification of sesame seed allergens by 2-dimensional proteomics and Edman sequencing: seed storage proteins as common food allergens

    J Allergy Clin Immunol

    (2002)
  • E.A. Pastorello et al.

    The major allergen of sesame seeds (Sesamum indicum) is a 2S albumin

    J Chromatogr B Biomed Sci Appl

    (2001)
  • J.O. Hourihane et al.

    Resolution of peanut allergy: case-control study

    BMJ

    (1998)
  • D.A. Moneret-Vautrin et al.

    Epidemiology of life-threatening and lethal anaphylaxis: a review

    Allergy

    (2005)
  • H.A. Sampson et al.

    Fatal and near-fatal anaphylactic reactions to food in children and adolescents

    N Engl J Med

    (1992)
  • Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment (COT). Adverse reactions to food and food ingredients

    London (United Kingdom): Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment

    (1998)
  • Cited by (0)

    Supported by a research grant from the National Peanut Board, United States. This grant supported the project costs, including the salary of G.D.T. over the study duration. G.L.'s salary was in part supported by the Aimwell Foundation. Support was also provided by the Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre award to Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London.

    Disclosure of potential conflict of interest: G. Du Toit has received research support from the Immune Tolerance Network and the National Peanut Board, United States. Y. Katz has received research support from the Israel Dairy Board and has provided legal consultation or expert witness testimony on the subject of milk exposure. S. J. Maleki has received research support from the Georgia Peanut Commission. V. Turcanu has received research support from the Food Standards Agency (UK), the National Peanut Board, United States, the Immune Tolerance Network, and the Food Allergy and Anaphylaxis Network. G. Lack has consulted for the advisory boards of Synovate, Novartis-Xolair, and ALK-Abelló; has given lectures supported by SHS Nutricia, SHS International, and Nestlé; has received research support from the Immune Tolerance Network, the National Peanut Board, United States, the Food Standard Agency, the Food Allergy Initiative, the Food Allergy and Anaphylaxis Network, and the Medical Research Council; and has served as a scientific advisor for the Anaphylaxis Campaign and the National Peanut Board, United States. The rest of the authors have declared that they have no conflict of interest.

    View full text